Christoph Anthuber
1 Papers
Christoph Anthuber is an academic researcher. The author has contributed to research in topics: Internal medicine & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
Jacobus Pfisterer,Catherine M Shannon,Klaus Baumann,Joern Rau,Philipp Harter,Florence Joly,Jalid Sehouli,Ulrich Canzler,Barbara Schmalfeldt,Barbara Schmalfeldt,Andrew Dean,Alexander Hein,Alain G. Zeimet,Lars Hanker,Thierry Petit,Frederik Marmé,Ahmed El-Balat,Rosalind Glasspool,Nikolaus de Gregorio,Sven Mahner,Sven Mahner,Tarek M Meniawy,Tjoung-Won Park-Simon,Marie-Ange Mouret-Reynier,Cristina Costan,Werner Meier,Alexander Reinthaller,Jeffrey C Goh,Tifenn Lharidon,Sally Baron Hay,Stefan Kommoss,Andreas du Bois,Jean-Emmanuel Kurtz,Sven Ackermann,Christoph Anthuber,Mustafa Aydogdu,Angelika Baldauf,Wolfgang Bauer,Dirk Behringer,Antje Belau,Alexandra Bender,C Brucker,Alexander Burges,Trygve Daabach,Dominik Denschlag,Mustafa Deryal,Steffen Dörfel,Juliane Ebert,Tanja Fehm,Susanne Maria Feidicker,Gabriele Feisel-Schwickardi,Ricardo Felberbaum,Matthias Frank,Gerhard Gebauer,Bernd Gerber,Axel Gerhardt,Andrea Grafe,Martin Griesshammer,Eva-Maria Grischke,Isolde Gröll,Martina Gropp-Meier,Dietrich Hager,Volker Hanf,Carla Verena Hannig,Peer Hantschmann,Tanja Hauzenberger,Uwe Herwig,Martin Heubner,Carsten Hielscher,Felix Hilpert,Thomas Hitschold,Manfred Hofmann,Christian Jackisch,Wolfgang Janni,Ludwig Kiesel,Yon-Dschun Ko,Hans-Joachim Koch,Petra Krabisch,Peter Krieger,Thomas Kubin,Thorsten Kühn,Björn Lampe,Peter Ledwon,Sabine Lemster,Benno Lex,Clemens Liebrich,Ralf Lorenz,Hans-Joachim Lück,Peter Mallmann,Wolfgang Meinerz,Götz Menke,Volker Möbus,Thomas G. Müller,Volker Müller,Tanja Neunhöffer,Angelika Ober,G. Oskay-Özcelik,Horst Ostertag,Martin Pölcher,Beate Rautenberg,Daniel Rein,Wilhelm Reiter,Andreas Rempen,Ingo B. Runnebaum,Marcus Schmidt,Sabine Schnohr,Heinz Scholz,Willibald Schröder,Eike Simon,Antje Sperfeld,Annette Steckkönig,Hans-Georg Strauß,Ronaldo Stuth,Jürgen Terhaag,Falk Thiel,Marc Thill,Oliver Tomé,Christoph Uleer,Susanne Vogel,Hermann Voß,Michael Weigel,Ulrich Winkler,Arthur Wischnik,Tobias Zeiser,Andreas Zorr,R.M. Glasspool,Emma Hudson,Rachel Jones,Judith Lafleur,Christian Marth,Edgar Petru,Yoland Antill,Mary Azer,Sally Baron-Hay,Philip Beale,Stephen Begbie,Allison Black,Karen Briscoe,Andrew Dean,Jeffrey C. Goh,Sandra Harvey,Chee Lee,Marco Matos,Tarek Meniawy,Inger Olesen,Catherine Shannon,Paul A. Vasey,Sophie Abadie-Lacourtoisie,Olivier Arsene,Sophie Barthier,Célia Becuwe-Roemer,Dominique Berton-Rigaud,Maria Cappiello-Bataller,Stéphanie Catala,Francesco Del Piano,Gael Deplanque,Raymond Despax,Nadine Dohollou,Claire Garnier-Tixidré,Julien Grenier,Emmanuel Guardiola,Anne-Claire Hardy-Bessard,Claudia Lefeuvre-Plesse,Marianne Leheurteur,Anne Lesoin,Charles-Briac Levache,Raffaele Longo,Alain Lortholary,Jérôme Meunier,Nadia Raban,Olivier Romano,Jean-Michel Vannetzel,Alain Zannetti +172 more
TL;DR: This multicentre, open-label, randomised, phase 3 trial was to compare a standard bevacizumab-containing regimen versus carboplatin-pegylated liposomal doxorubicin combined with bevacsumab for progression-free survival in recurrent ovarian cancer.